BIOV:CC News and Press, Biovaxys Technology Corp. From 04/17/23

BIOVAXYS RETAINS MAXIM GROUP AS FINANCIAL ADVISOR AND INVESTMENT BANKER Canada NewsWire VANCOUVER, British Columbia , April 17, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce tha...

BIOVAXYS ANNOUNCES APPOINTMENT OF CFO AND BOARD CHANGES Canada NewsWire VANCOUVER, BC , April 12, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce that Dasha Enenko has been appoin...

--News Direct-- BioVaxys CEO James Passin joins Natalie Stoberman from the Proactive newsroom to discuss the company's acquisition of TAETSoftware, a Vancouver-based clinical studies management company engaged in the development and commercialization of the Trial Adverse Events Tracker (TAET)...

VANCOUVER, BC / ACCESSWIRE / March 16, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Spey Resources, Melkior Resources and BioVaxys Technology discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapshot...

BIOVAXYS ACQUIRES CLINICAL STUDY MANAGEMENT COMPANY AND COMPLETES PRIVATE PLACEMENT PR Newswire VANCOUVER, BC , March 16, 2023 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") today announced that it h...

VANCOUVER, BC / ACCESSWIRE / December 20, 2022 / The Power Play by The Market Herald has announced the release of new interviews with ApartmentLove, Sirios Resources, Aton Resources, Mountain Boy Minerals and BioVaxys Technology discussing their latest news. The Power Play by The Market Herald ...

BioVaxys and Procare Health Execute US Distribution Agreement for Papilocare Gel and Oral Immunocaps Canada NewsWire VANCOUVER , British Colombia and BARCELONA, Spain , Dec. 19, 2022 /CNW/ - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ...

BioVaxys Co-Founder, President and Chief Operating Officer Kenneth Kovan to Present at MedInvest Oncology Investor Conference Canada NewsWire VANCOUVER, BC , Dec. 5, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxy...

Palm Beach, FL – December 1, 2022 – FinancialNewsMedia.com News Commentary – The global ovarian cancer market is projected to continue to grow through the coming several years. The formation of mutational cells or tissues in female reproductive organs called ovari...

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine Canada NewsWire VANCOUVER, BC , Dec. 1, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announ...